Adam Mikstacki
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Nosocomial Infections in ICU 7
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Barbara Tamowicz (10 shared papers)Ryszard Słomski (10 shared papers)Marzena Skrzypczak-Zielińska (10 shared papers)Krzysztof Szyfter (2 shared papers)Oliwia Zakerska‐Banaszak (7 shared papers)Marlena Szalata (9 shared papers)Małgorzata Rydzanicz (1 shared paper)Marta Molińska-Glura (3 shared papers)
In The Last Decade
Adam Mikstacki
32 papers receiving 1.3k citations
Adam Mikstacki's Hit Papers
Peers
Comparison fields: 5 of 86
- Applied Microbiology and Biotechnology 132
- Molecular Medicine 229
- Critical Care and Intensive Care Medicine 162
- Clinical Biochemistry 58
- Infectious Diseases 185
Countries citing papers authored by Adam Mikstacki
This map shows the geographic impact of Adam Mikstacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Mikstacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Mikstacki more than expected).
Fields of papers citing papers by Adam Mikstacki
This network shows the impact of papers produced by Adam Mikstacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Mikstacki. The network helps show where Adam Mikstacki may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam Mikstacki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 348 | |
| 2 | 2014 | 189 | |
| 3 | Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study Hit paper breakdown → | 2023 | 168 |
| 4 | 2019 | 137 | |
| 5 | 2016 | 69 | |
| 6 | Genotoxicity of inhalation anaesthetics: DNA lesions generated by sevoflurane in vitro and in vivo. | 2004 | 59 |
| 7 | 2022 | 42 | |
| 8 | 2022 | 40 | |
| 9 | 2016 | 32 | |
| 10 | 2022 | 32 | |
| 11 | 2013 | 27 | |
| 12 | Genotoxicity of the volatile anaesthetic desflurane in human lymphocytes in vitro, established by comet assay. | 2005 | 24 |
| 13 | 2011 | 24 | |
| 14 | 2021 | 20 | |
| 15 | 2013 | 14 | |
| 16 | 2016 | 13 | |
| 17 | 2021 | 13 | |
| 18 | 2014 | 12 | |
| 19 | 2012 | 10 | |
| 20 | 2019 | 9 |
About Adam Mikstacki
Adam Mikstacki is a scholar working on Critical Care and Intensive Care Medicine, Pharmacology, Epidemiology, Infectious Diseases and Molecular Medicine, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (10 papers), Nosocomial Infections in ICU (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Infection Control in Healthcare (4 papers), Glutathione Transferases and Polymorphisms (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (132 citations), Molecular Medicine (229 citations), Critical Care and Intensive Care Medicine (162 citations), Clinical Biochemistry (58 citations) and Infectious Diseases (185 citations). Adam Mikstacki has collaborated with scholars based in Poland, France and Belgium. Frequent co-authors include Barbara Tamowicz, Ryszard Słomski, Marzena Skrzypczak-Zielińska, Krzysztof Szyfter, Oliwia Zakerska‐Banaszak, Marlena Szalata, Małgorzata Rydzanicz, Marta Molińska-Glura, Magdalena Kostrzewska‐Poczekaj and Despoina Koulenti. Their work appears in journals such as Intensive Care Medicine, Critical Care, The Lancet, International Journal of Antimicrobial Agents and Advances in Clinical and Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.